Milrinone Lactate Injection, Solution
Product Images NDC 70069-809

This is a product label for Milrinone Lactate Injection, a medication used for intravenous use only. Each mL contains milrinone lactate equivalent to 1 mg milrinone and 47 mg dextrose anhydrous. This medication does not contain a preservative. The package is for 10 x 10mL single-dose vials. The varnished area of the packaging is left blank for batch overprinting purposes. The product is manufactured in India by Caplin Steriles Limited and distributed by Somerset Therapeutics in Hollywood, Florida.*

Milrinone Lactate Injection is a prescription drug that is meant to be administered intravenously. Each mL contains 10 mg of milrinone lactate and 47 mg of dextrose anhydrous, USP, in water for injection, USP. The pH of the drug is adjusted between 3.2 and 4.0 with lactic acid and/or sodium hydroxide. The drug is stored at 20° to 25°C (68° to 77°F), and unused portions should be discarded. The drug does not contain a preservative, and it is manufactured by Caplin Steriles Limited in India and marketed by Somerset Therapeutics in Hollywood, FL. The drug is available in a 10 mL single-dose vial. The recommended dosage should be obtained from the package insert.*

This is Milrinone Lactate Injection, USP, a drug used for intravenous use only with a concentration of 20 mg/20 mL (1 mg/mL). Each vial contains 20 mL of the injection, and each mL contains milrinone lactate equivalent to 1 mg milrinone and 47 mg dextrose anhydrous, USP, in water for injection, USP. The usual dosage is not specified, and the product should be stored at 20° to 25°C (68° to 77°F). The drug is manufactured in India by Caplin Steriles Limited for Somerset Therapeutics LLC based in Hollywood, FL, USA. It comes in a package of ten single-dose vials, and each vial is 65.00 mm in size.*

Milrinone Lactate Injection, USP is a prescription medicine that is given through the veins (intravenous (IV) use) only. It is supplied in a 20 mL single-dose vial and contains 20 mg of milrinone lactate, which is equivalent to 1mg/mL. Each mL of the injection has milrinone lactate (1 mg), dextrose anhydrous (47mg/), and water for injection, USP. The pH of the injection is adjusted between 3.2 and 4.0 using lactic acid and/or sodium hydroxide, and lactic acid concentration varies between 0.95 mg/mL and 1.29 mg/mL. It is important to note that the usual dosage should be determined based on the patient's condition, and instructions are provided in the package insert. Milrinone Lactate Injection should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F), protected from freezing. Discard any unused portion. The product label indicates that it does not contain a preservative. This medication is manufactured by Caplin Steriles Limited, India, and is made available by Somerset Therapeutics, LLC based in Hollywood, FL, USA.*

Milrinone Lactate Injection, USP is a prescription medicine available in single-dose vials for intravenous administration only. Each mL contains 1 mg of milrinone and 47 mg of dextrose anhydrous, USP, in water. It does not contain a preservative. The total concentration of lactic acid can range from 0.95 mg/mL to 1.29 mg/mL, and the pH is adjusted between 3.2 and 4.0. The usual dosage is described in the package insert. It is manufactured by Caplin Steriles Limited, India and distributed by Somerset Therapeutics, LLC in Hollywood, FL. Store it at a controlled room temperature between 20 to 25 °C (68 to 77 °F) and avoid freezing. Discard any unused portion.*